Most linked-to pages

Showing below up to 246 results in range #1 to #246.

1. Main Page‏‎ (152 links)
2. Educational Materials‏‎ (81 links)
3. Diagnostic Kits‏‎ (78 links)
4. Biotechnology - Genomic and Proteomics‏‎ (40 links)
5. Alternative Energy‏‎ (37 links)
6. The K-12 Level‏‎ (22 links)
7. The Higher Education Level‏‎ (20 links)
8. Overall Picture of the EM field‏‎ (20 links)
9. Contacts for EM‏‎ (20 links)
10. Report April 2009‏‎ (19 links)
11. Bibliography for Item 2 in EM‏‎ (18 links)
12. Commons-based Cases in EM‏‎ (16 links)
13. Pearson‏‎ (15 links)
14. Telecommunications‏‎ (14 links)
15. Alternative Energy/Bibliography by Research Question‏‎ (14 links)
16. Educational Materials/Bibliography by Research Question‏‎ (14 links)
17. IP Profile of Biggest for-profit companies in EM‏‎ (14 links)
18. User:EGraeff‏‎ (12 links)
19. ICP Team‏‎ (12 links)
20. Bibliography for Item 6 in EM‏‎ (11 links)
21. IP Profile of Biggest for-profit companies in EM-K12‏‎ (10 links)
22. McGraw-Hill‏‎ (10 links)
23. ICP Reports and Working Papers‏‎ (9 links)
24. Diagnostic Kits/A pilot survey on the licensing of DNA inventions‏‎ (9 links)
25. Cengage Learning‏‎ (9 links)
26. Diagnostic Kits/The licensing of DNA patents by US academic institutions‏‎ (9 links)
27. Commons-based Cases in EM-K12‏‎ (9 links)
28. Alternative Business Models in EM‏‎ (9 links)
29. Diagnostic Kits/A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions‏‎ (9 links)
30. Overall Picture of the EM-K12 field‏‎ (9 links)
31. Diagnostic Kits/Analysing DNA patents in relation with diagnostic genetic testing‏‎ (9 links)
32. ICP Parking Lot‏‎ (8 links)
33. IP Profile of Universities working in EM‏‎ (8 links)
34. Textbooks‏‎ (8 links)
35. Data, narratives and tools produced by the EM field‏‎ (8 links)
36. Diagnostic Kits/DNA-based patents: an empirical analysis‏‎ (8 links)
37. Diagnostic Kits/Diagnostic testing fails the test‏‎ (8 links)
38. IP Profile of non-profit companies in EM‏‎ (8 links)
39. User:WikiSysop‏‎ (8 links)
40. Diagnostic Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care‏‎ (8 links)
41. IP Profile of Biggest for-profit companies in AE‏‎ (8 links)
42. Diagnostic Kits/Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing‏‎ (8 links)
43. California‏‎ (8 links)
44. Overview of Economics of Intellectual Property in EM‏‎ (7 links)
45. Data, narratives and tools produced by the EM-K12 field‏‎ (7 links)
46. Diagnostic Kits/Disease Gene Patents‏‎ (7 links)
47. Bibliography for Item 3 in EM‏‎ (7 links)
48. Diagnostic Kits/DNA Patenting and Licensing‏‎ (7 links)
49. Houghton Mifflin‏‎ (7 links)
50. Diagnostic Kits/Intellectual Property Landscape of the Human Genome‏‎ (7 links)
51. ICP Sectors‏‎ (7 links)
52. Diagnostic Kits/Glossary‏‎ (7 links)
53. Diagnostic Kits/Effects of patents and licenses on the provision of clinical genetic testing services‏‎ (7 links)
54. Industrial Cooperation Project‏‎ (7 links)
55. Diagnostic Kits/Models for facilitating access to patents on genetic inventions‏‎ (7 links)
56. Give an overall picture of the AE field‏‎ (7 links)
57. Diagnostic Kits/Patent pools and diagnostic testing‏‎ (7 links)
58. IP in EM‏‎ (7 links)
59. IP Profile of Associations in EM-K12‏‎ (7 links)
60. Defining the Commons‏‎ (6 links)
61. Country AE Profiles‏‎ (6 links)
62. IP Profile of Universities working in Kits‏‎ (6 links)
63. IP Profile of Associations in EM‏‎ (6 links)
64. Wiley‏‎ (6 links)
65. Diagnostic Kits/Country Reports Review‏‎ (6 links)
66. Competitive advantages in EM‏‎ (6 links)
67. Give an overall picture of the Kits' sector‏‎ (6 links)
68. IP Profile of Biggest for-profit companies in BGP‏‎ (6 links)
69. Diagnostic Kits/Case Law Review‏‎ (6 links)
70. Diagnostic Kits/Bibliography‏‎ (5 links)
71. Overview of Economics of Intellectual Property in EM-K12‏‎ (5 links)
72. Commons based cases in AE‏‎ (5 links)
73. IP Profile of non-profit companies in AE‏‎ (5 links)
74. IP Profile of Universities working in EM-K12‏‎ (5 links)
75. Diagnostic Kits/Priorities for Personalized Medicine‏‎ (5 links)
76. Innovations in Wind, Solar and Tidal‏‎ (5 links)
77. Erhardt Graeff‏‎ (5 links)
78. IP Profile of non-profit companies in EM-K12‏‎ (5 links)
79. Verlagsgruppe Georg von Holtzbrinck‏‎ (5 links)
80. Diagnostic Kits/Diagnosis or drug- Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine‏‎ (5 links)
81. Field Research Methodology‏‎ (5 links)
82. IP in Kits‏‎ (5 links)
83. IP in EM-K12‏‎ (5 links)
84. IP Profile of Associations in AE‏‎ (5 links)
85. Alternative Business Models in EM-K12‏‎ (5 links)
86. Diagnostic Kits/USA Regulation Review‏‎ (5 links)
87. Competitive advantages in EM-K12‏‎ (5 links)
88. Data, narratives and tools produced by the Kits' sector‏‎ (5 links)
89. IP Profile of Biggest for-profit companies in Kits‏‎ (4 links)
90. Legislation on Policy Theme 8 for EM‏‎ (4 links)
91. Texas‏‎ (4 links)
92. IP Profile of Universities working in AE‏‎ (4 links)
93. Diagnostic Kits/Patents versus patenting: implications of intellectual property protection for biological research‏‎ (4 links)
94. IP Profile of non-profit companies in Kits‏‎ (4 links)
95. Legislation on Policy Theme 1 for EM‏‎ (4 links)
96. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices‏‎ (4 links)
97. Legislation on Policy Theme 9 for EM‏‎ (4 links)
98. Houghton Mifflin Harcourt‏‎ (4 links)
99. Open Business models in Kits‏‎ (4 links)
100. Legislation on Policy Theme 2 for EM‏‎ (4 links)
101. Diagnostic Kits/Patents and the Progress of Personalized Medicine‏‎ (4 links)
102. IP in AE‏‎ (4 links)
103. Overview of Economics of Intellectual Property in Kits‏‎ (4 links)
104. Legislation on Policy Theme 3 for EM‏‎ (4 links)
105. Methodology‏‎ (4 links)
106. Paper‏‎ (4 links)
107. Legislation on Policy Theme 4 for EM‏‎ (4 links)
108. Overview of Economics of Intellectual Property in AE‏‎ (4 links)
109. Diagnostic Kits/Clinically Available Pharmacogenomics Tests‏‎ (4 links)
110. Commons based cases in Kits‏‎ (4 links)
111. Peer-Production Business models in Kits‏‎ (4 links)
112. Legislation on Policy Theme 5 for EM‏‎ (4 links)
113. ICP Main Questions‏‎ (4 links)
114. Florida‏‎ (4 links)
115. Competitive advantages in Kits‏‎ (4 links)
116. Legislation on Policy Theme 6 for EM‏‎ (4 links)
117. SACGHS Appendix 1- Compendium of Case Studies on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing‏‎ (4 links)
118. IP Profile of Associations in Kits‏‎ (4 links)
119. Legislation on Policy Theme 7 for EM‏‎ (4 links)
120. Diagnostic Kits/The dangers of diagnostic monopolies‏‎ (4 links)
121. Reed Elsevier‏‎ (4 links)
122. Bibliography for Item 1 in EM‏‎ (4 links)
123. Jonathan Emmons Interview Notes‏‎ (3 links)
124. Alternative Energy/Paper‏‎ (3 links)
125. Diagnostic Kits/Diagnostic Test Service Commercialization- A Roadmap to Diagnostics in the 21st Century‏‎ (3 links)
126. Competitive advantages in BGP‏‎ (3 links)
127. IP Profile of non-profit companies in BGP‏‎ (3 links)
128. Cathy Swift Interview Notes - September 21, 2009‏‎ (3 links)
129. Harcourt Education‏‎ (3 links)
130. Andrew Clearwater‏‎ (3 links)
131. Diagnostic Kits/The Search for Alternatives to Patents in the 21st Century‏‎ (3 links)
132. Report September 2009‏‎ (3 links)
133. Diagnostic Kits/Diagnostics and biomarker development- priming the pipeline‏‎ (3 links)
134. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices Final Report‏‎ (3 links)
135. IP in BGP‏‎ (3 links)
136. Bibliography for Item 7 in AE‏‎ (3 links)
137. United States Country Report (Diagnostic Kits)‏‎ (3 links)
138. Diagnostic Kits/SACGHS U.S. System of Oversight of Genetic Testing‏‎ (3 links)
139. History of EM Field‏‎ (3 links)
140. Open Business models in BGP‏‎ (3 links)
141. BGP Table of Biggest For-Profit Companies‏‎ (3 links)
142. Ahrash Bissell Interview Notes - July 20, 2009‏‎ (3 links)
143. Hal Plotkin Interview Notes - August 10, 2009‏‎ (3 links)
144. Bibliography for Item 4 in EM‏‎ (3 links)
145. Economics of Intellectual Property‏‎ (3 links)
146. Diagnostic Kits/Testing new ground‏‎ (3 links)
147. Give an overall picture of the BGP field‏‎ (3 links)
148. Overview of Economics of Intellectual Property in BGP‏‎ (3 links)
149. Ahrash Bissell Interview Notes - May 12, 2009‏‎ (3 links)
150. Joel Thierstein Interview Notes - August 19, 2009‏‎ (3 links)
151. Bibliography for Item 5 in EM‏‎ (3 links)
152. All Bibliographic Sources‏‎ (3 links)
153. Diagnostic Kits/Interviews‏‎ (3 links)
154. Diagnostic Kits/Bibliography by Research Question‏‎ (3 links)
155. Bibliography for Item 2 in AE‏‎ (3 links)
156. Anne Schreiber Interview Notes - August 27, 2009‏‎ (3 links)
157. AE Essay on EFRC Survey‏‎ (3 links)
158. Kathi Fletcher Interview Notes - August 26, 2009‏‎ (3 links)
159. Ahrash Bissell Interview Notes‏‎ (3 links)
160. IP Profile of Associations in BGP‏‎ (3 links)
161. Sage - A Merck Project‏‎ (3 links)
162. Neeru Khosla Interview Notes - September 4, 2009‏‎ (3 links)
163. Bibliography for Item 10 in EM‏‎ (3 links)
164. Bibliography for Item 7 in EM‏‎ (3 links)
165. Brendan Ballou‏‎ (3 links)
166. Diagnostic Kits/Bibliography by Resource Type‏‎ (3 links)
167. Diagnostic Kits/Legal uncertainty in the area of genetic diagnostic testing‏‎ (3 links)
168. Vaccines‏‎ (3 links)
169. Bibliography for Item 2 in BGP‏‎ (3 links)
170. Bill Hughes Interview Notes - October 7, 2009‏‎ (3 links)
171. Peter Levy Interview Notes - September 18, 2009‏‎ (3 links)
172. Bibliography for Item 11 in EM‏‎ (3 links)
173. Bibliography for Item 8 in EM‏‎ (3 links)
174. Commons based cases in BGP‏‎ (3 links)
175. IP Profile of Universities working in BGP‏‎ (3 links)
176. Bobbi Kurshan Interview Notes - August 17, 2009‏‎ (3 links)
177. Bibliography for Item 9 in EM‏‎ (3 links)
178. Diagnostic Kits/Commons based cases in Kits‏‎ (3 links)
179. Diagnostic Kits/Secretary's Advisory Committee on Genetics‏‎ (2 links)
180. Meeting ICP + OCP‏‎ (2 links)
181. Educational Materials/Interviews‏‎ (2 links)
182. W:Wikipedia:Template documentation‏‎ (2 links)
183. Biotechnology - Genomic and Proteomics/IP in BGP‏‎ (2 links)
184. Walt Musial‏‎ (2 links)
185. User:Mac/Research Question‏‎ (2 links)
186. History of US Textbook Publishing‏‎ (2 links)
187. Data, narratives and tools produced by the BGP field‏‎ (2 links)
188. Bibliography for Item 7 in BGP‏‎ (2 links)
189. Biotechnology - Genomic and Proteomics/Competitive advantages in BGP‏‎ (2 links)
190. Eric Frank Interview Notes - October 22, 2009‏‎ (2 links)
191. Lessons from ANT‏‎ (2 links)
192. Diagnostic Kits/Give an overall picture of the Kits' sector‏‎ (2 links)
193. Meeting with Yochai‏‎ (2 links)
194. Competitive advantages in AE‏‎ (2 links)
195. Diagnostic Kits/Direct-to-consumer genetic testing- two sides of the coin‏‎ (2 links)
196. Bibliography for Item 8 in BGP‏‎ (2 links)
197. Bibliography for Item 12 in BGP‏‎ (2 links)
198. Posts for ICP Blog‏‎ (2 links)
199. Diagnostic Kits/Morrison and Foerster Represents ACON Laboratories in $175 Million Acquisition by Inverness Medical Innovations‏‎ (2 links)
200. Bibliography for Item 3 in BGP‏‎ (2 links)
201. Bibliography for Item 9 in BGP‏‎ (2 links)
202. Jonathan Emmons Interview Notes - March 25, 2009‏‎ (2 links)
203. Michael Steffen‏‎ (2 links)
204. Diagnostic Kits/Genes and ingenuity: gene patenting and human health report‏‎ (2 links)
205. Diagnostic Kits/NIH Principles and Guidelines for Sharing of Biomedical Resources‏‎ (2 links)
206. Diagnostic Kits/The market economy, and the scientific commons‏‎ (2 links)
207. Bibliography for Item 4 in BGP‏‎ (2 links)
208. Government in BGP‏‎ (2 links)
209. Peer-Production Business models in BGP‏‎ (2 links)
210. Report May 2009‏‎ (2 links)
211. User:Mac/Interviews‏‎ (2 links)
212. Blogs to watch on EM‏‎ (2 links)
213. Diagnostic Kits/The Argument Framework‏‎ (2 links)
214. Links on EM‏‎ (2 links)
215. Questionnaire for Case Studies‏‎ (2 links)
216. Diagnostic Kits/Nonenforcement, Noneproblem Rethinking the Anticommons in Biomedical Research‏‎ (2 links)
217. Biotechnology - Genomic and Proteomics/Bibliography by Research Question‏‎ (2 links)
218. Bibliography for Item 3 in AE‏‎ (2 links)
219. Bibliography for Item 1 in BGP‏‎ (2 links)
220. Bibliography for Item 5 in BGP‏‎ (2 links)
221. Bibliography for Item 10 in BGP‏‎ (2 links)
222. Biotechnology - Genomic and Proteomics/Overview of Economics of Intellectual Property in BGP‏‎ (2 links)
223. Anne Schreiber Interview Notes - August 31, 2009‏‎ (2 links)
224. ICP Parking Lot/Sustainability‏‎ (2 links)
225. Diagnostic Kits/USA Regulation‏‎ (2 links)
226. Diagnostic Kits/Biotechnology and Intellectual Property Reinventing the Commons‏‎ (2 links)
227. Diagnostic Kits/Patents and translational research in genomics‏‎ (2 links)
228. Biotechnology - Genomic and Proteomics/Others‏‎ (2 links)
229. Biotechnology - Genomic and Proteomics/Give an overall picture of the BGP field‏‎ (2 links)
230. Introduction to Telecommunications Industries‏‎ (2 links)
231. Jeremy M. Firestone‏‎ (2 links)
232. User:Mac/The Problems of Patents on Diagnostic Testing Kits‏‎ (2 links)
233. Data, narratives and tools produced by the Kits' sector/GeneDxChart‏‎ (2 links)
234. Interviews for Blog‏‎ (2 links)
235. Meeting Fellow + RAs‏‎ (2 links)
236. Silas Bauer‏‎ (2 links)
237. Alternative Energy/Bibliography by Resource Type‏‎ (2 links)
238. Diagnostic Kits/Patents limit medical potential of sequencing‏‎ (2 links)
239. Educational Materials/Bibliography by Resource Type‏‎ (2 links)
240. Template:Xpd‏‎ (2 links)
241. Bibliography for Item 4 in AE‏‎ (2 links)
242. Bibliography for Item 6 in BGP‏‎ (2 links)
243. E-Book Readers‏‎ (2 links)
244. Biotechnology - Genomic and Proteomics/Data, narratives and tools produced by the BGP field‏‎ (2 links)
245. Bibliography for Item 11 in BGP‏‎ (2 links)
246. ICP Complete Bibliography‏‎ (2 links)